Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registryMargaret Meagher, Ithaar Derweesh, Siska Van Bruwaene et al.|European Urology Open Science|2020Cited by 2
MP25-12 PREDICTORS OF MAJOR COMPLICATIONS AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: INSIGHTS FROM A RETROSPECTIVE MULTICENTRE REGISTRYR. Campi, Maria Carmen Mir, Maximilian C. Kriegmair et al.|The Journal of Urology|2019Cited by 0
Open versus minimally invasive cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC): Results from a multicenter retrospective studyM.C. Mir, Andrea Minervini, Riccardo Campi et al.|European Urology Supplements|2019Cited by 0
MP14-07 PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCOREM Mir, Michele Marchioni, Riccardo Campi et al.|The Journal of Urology|2020Cited by 0